Terms: = Breast cancer AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3
52 results:
1. breast cancer in a Hispanic patient with Werner syndrome.
Santos MM; Baerga CG; Lamsal S; Engel C; Ozdemir S
J Radiol Case Rep; 2023 Oct; 17(10):21-31. PubMed ID: 38343885
[TBL] [Abstract] [Full Text] [Related]
2. Co-Occurrence of Germline Genomic Variants and Copy Number Variations in Hereditary breast and Colorectal cancer Patients.
Côrtes L; Basso TR; Villacis RAR; Souza JDS; Jørgensen MMA; Achatz MI; Rogatto SR
Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628631
[TBL] [Abstract] [Full Text] [Related]
3. wrn rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer.
Datta A; Brosh RM
Bioessays; 2022 Aug; 44(8):e2200057. PubMed ID: 35751457
[TBL] [Abstract] [Full Text] [Related]
4. Non-enzymatic function of wrn RECQL helicase regulates removal of topoisomerase-I-DNA covalent complexes and triggers NF-κB signaling in cancer.
Gupta P; Majumdar AG; Patro BS
Aging Cell; 2022 Jun; 21(6):e13625. PubMed ID: 35582959
[TBL] [Abstract] [Full Text] [Related]
5. Resistance to DNA repair inhibitors in cancer.
Baxter JS; Zatreanu D; Pettitt SJ; Lord CJ
Mol Oncol; 2022 Nov; 16(21):3811-3827. PubMed ID: 35567571
[TBL] [Abstract] [Full Text] [Related]
6. Usefulness of Human Jejunal Spheroid-Derived Differentiated Intestinal Epithelial Cells for the Prediction of Intestinal Drug Absorption in Humans.
Michiba K; Maeda K; Shimomura O; Miyazaki Y; Hashimoto S; Oda T; Kusuhara H
Drug Metab Dispos; 2022 Mar; 50(3):204-213. PubMed ID: 34992074
[TBL] [Abstract] [Full Text] [Related]
7. The wrn helicase: resolving a new target in microsatellite unstable cancers.
van Wietmarschen N; Nathan WJ; Nussenzweig A
Curr Opin Genet Dev; 2021 Dec; 71():34-38. PubMed ID: 34284257
[TBL] [Abstract] [Full Text] [Related]
8. HERC2 inactivation abrogates nucleolar localization of RecQ helicases BLM and wrn.
Zhu M; Wu W; Togashi Y; Liang W; Miyoshi Y; Ohta T
Sci Rep; 2021 Jan; 11(1):360. PubMed ID: 33432007
[TBL] [Abstract] [Full Text] [Related]
9. NRG1 fusions in breast cancer.
Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
[TBL] [Abstract] [Full Text] [Related]
10. Werner Syndrome Protein Expression in breast cancer.
Savva C; Sadiq M; Sheikh O; Karim S; Trivedi S; Green AR; Rakha EA; Madhusudan S; Arora A
Clin Breast Cancer; 2021 Feb; 21(1):57-73.e7. PubMed ID: 32919863
[TBL] [Abstract] [Full Text] [Related]
11. Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Heeke AL; Xiu J; Elliott A; Korn WM; Lynce F; Pohlmann PR; Isaacs C; Swain SM; Vidal G; Schwartzberg LS; Tan AR
Breast Cancer Res Treat; 2020 Nov; 184(2):265-275. PubMed ID: 32776290
[TBL] [Abstract] [Full Text] [Related]
12. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract] [Full Text] [Related]
13. Gene Panel Testing in Hereditary breast cancer.
Rostami P; Zendehdel K; Shirkoohi R; Ebrahimi E; Ataei M; Imanian H; Najmabadi H; Akbari MR; Sanati MH
Arch Iran Med; 2020 Mar; 23(3):155-162. PubMed ID: 32126783
[TBL] [Abstract] [Full Text] [Related]
14. Identifying sequence variants contributing to hereditary breast and ovarian cancer in BRCA1 and BRCA2 negative breast and ovarian cancer patients.
Jarhelle E; Riise Stensland HMF; Hansen GÅM; Skarsfjord S; Jonsrud C; Ingebrigtsen M; Strømsvik N; Van Ghelue M
Sci Rep; 2019 Dec; 9(1):19986. PubMed ID: 31882575
[TBL] [Abstract] [Full Text] [Related]
15. Recommendations for Preventive Care for Women with Rare Genetic Cause of breast and Ovarian cancer.
Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
[TBL] [Abstract] [Full Text] [Related]
16. HERC2 Facilitates BLM and wrn Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA.
Wu W; Rokutanda N; Takeuchi J; Lai Y; Maruyama R; Togashi Y; Nishikawa H; Arai N; Miyoshi Y; Suzuki N; Saeki Y; Tanaka K; Ohta T
Cancer Res; 2018 Nov; 78(22):6371-6385. PubMed ID: 30279242
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in breast cancers.
Green AR; Aleskandarany MA; Ali R; Hodgson EG; Atabani S; De Souza K; Rakha EA; Ellis IO; Madhusudan S
Cancer Immunol Res; 2017 Apr; 5(4):292-299. PubMed ID: 28254786
[TBL] [Abstract] [Full Text] [Related]
18. Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients.
Li Z; Heng J; Yan J; Guo X; Tang L; Chen M; Peng L; Wu Y; Wang S; Xiao Z; Deng Z; Dai L; Wang J
Breast Cancer Res Treat; 2016 Nov; 160(2):371-383. PubMed ID: 27722841
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of DNA Repair Genes Polymorphisms in breast cancer.
Romanowicz H; Pyziak Ł; Jabłoński F; Bryś M; Forma E; Smolarz B
Pathol Oncol Res; 2017 Jan; 23(1):117-123. PubMed ID: 27571987
[TBL] [Abstract] [Full Text] [Related]
20. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract] [Full Text] [Related]
[Next]
